Molecular, Cellular, and Developmental Biology Department, University of Colorado Boulder, Boulder, CO 80309, USA.
BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303, USA.
J Exp Biol. 2024 Oct 15;227(20). doi: 10.1242/jeb.247445. Epub 2024 Sep 30.
Some vertebrates evolved to have a remarkable capacity for anatomical and physiological plasticity in response to environmental challenges. One example of such plasticity can be found in the ambush-hunting snakes of the genus Python, which exhibit reversible cardiac growth with feeding. The predation strategy employed by pythons is associated with months-long fasts that are arrested by ingestion of large prey. Consequently, digestion compels a dramatic increase in metabolic rate and hypertrophy of multiple organs, including the heart. In this Review, we summarize the post-prandial cardiac adaptations in pythons at the whole-heart, cellular and molecular scales. We highlight circulating factors and cellular signaling pathways that are altered during digestion to affect cardiac form and function and propose possible mechanisms that may drive the post-digestion regression of cardiac mass. Adaptive physiological cardiac hypertrophy has also been observed in other vertebrates, including in fish acclimated to cold water, birds flying at high altitudes and exercising mammals. To reveal potential evolutionarily conserved features, we summarize the molecular signatures of reversible cardiac remodeling identified in these species and compare them with those of pythons. Finally, we offer a perspective on the potential of biomimetics targeting the natural biology of pythons as therapeutics for human heart disease.
一些脊椎动物进化出了对环境挑战的显著的解剖学和生理学可塑性。这种可塑性的一个例子可以在蟒属的伏击型猎食蛇类中找到,它们在进食时表现出心脏的可逆生长。蟒蛇采用的捕食策略与数月的禁食有关,这种禁食会因摄入大型猎物而停止。因此,消化迫使代谢率急剧增加,包括心脏在内的多个器官发生肥大。在这篇综述中,我们总结了蟒蛇在全心、细胞和分子水平上的餐后心脏适应。我们强调了在消化过程中发生改变的循环因子和细胞信号通路,这些改变会影响心脏的形态和功能,并提出可能驱动消化后心脏质量回归的潜在机制。适应性的生理性心肌肥大也在其他脊椎动物中观察到,包括适应冷水的鱼类、在高海拔飞行的鸟类和运动的哺乳动物。为了揭示潜在的进化保守特征,我们总结了在这些物种中发现的可逆性心肌重构的分子特征,并将它们与蟒蛇的特征进行了比较。最后,我们对针对蟒蛇自然生物学的仿生学作为人类心脏病治疗方法的潜力提出了看法。